COX 2 selectivity of non-steroidal anti-inflammatory drugs and perioperative blood loss in hip surgery. A randomized comparison of indomethacin and meloxicam

European Journal of Anaesthesiology

Volumn 20, Issue 12, 2003, Pages 963-966

  Weber, E W G ^a   Slappendel, R ^b   Durieux, M E ^a   Dirksen, R ^b   Van Der Heide, H ^b   Spruit, M ^b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b SINT MAARTENSKLINIEK   (Netherlands)

Author keywords

Analgesics, Non Narcotic, anti inflammatory agents, non steroidal; Arthroplasty, Replacement, Hip; Haemorrhage, blood loss, surgical

Indexed keywords

BUPIVACAINE; CYCLOOXYGENASE 2 INHIBITOR; INDOMETACIN; MELOXICAM; MIDAZOLAM; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG SELECTIVITY; FEMALE; HIP SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; PROSPECTIVE STUDY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHROPLASTY, REPLACEMENT, HIP; BLOOD LOSS, SURGICAL; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; FEMALE; HUMANS; INDOMETHACIN; ISOENZYMES; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; PERIOPERATIVE CARE; PROSPECTIVE STUDIES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; THIAZINES; THIAZOLES; TIME FACTORS;

EID: 0345059750     PISSN: 02650215     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0265021503001558     Document Type: Article

References (13)

1. Campbell WI, Kendrick R, Patterson C. Intravenous diclofenac sodium. Does its administration before operation suppress postoperative pain? Anaesthesia 1990; 45: 763-766.
2. Rorarius MG, Baer GA, Metsa-Ketela T, Miralles J, Palomaki E, Vapaatalo H. Effects of peri-operatively administered diclofenac and indomethacin on blood loss, bleeding time and plasma prostanoids in man. Eur J Anaesthesiol 1989; 6: 335-342.
3. Schafer AI. Effects of nonsteroidal antiinflammatory drugs on platelet function and systemic hemostasis. J Clin Pharmacol 1995; 35: 209-219.
4. Michot F, Ajdacic K, Glaus L. A double-blind clinical trial to determine if an interaction exists between diclofenac sodium and the oral anticoagulant acenocoumarol (nicoumalone). J Int Med Res 1975; 3: 153-157.
5. Pardo A, Garcia Losa M, Fernandez Pavon A, et al. A placebo-controlled study of interaction between nabumetone and acenocoumarol. Br J Clin Pharmacol 1999; 47: 441-444.
6. McKenna F. COX-2: separating myth from reality. Scand J Rheumatol Suppl 1999; 109: 19-29.
7. Vane JR, Botting RM. New insights into the mode of action of anti-inflammatory drugs. Inflamm Res 1995; 44: 1-10.
8. Meade EA, Smith WL, DeWitt DL. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem 1993; 268: 6610-6614.
9. de Meijer A, Vollaard H, de Metz M, Verbruggen B, Thomas C, Novakova I. Meloxicam, 15 mg/day, spares platelet function in healthy volunteers. Clin Pharmacol Ther 1999; 66: 425-430.
10. Stichtenoth DO, Wagner B, Frolich JC. Effects of meloxicam and indomethacin on cyclooxygenase pathways in healthy volunteers. J Investig Med 1997; 45: 44-49.
11. Giuliano F, Warner TD. Ex vivo assay to determine the cyclooxygenase selectivity of non-steroidal anti-inflammatory drugs. Br J Pharmacol 1999; 126: 1824-1830.
12. Perttunen K, Kalso E, Heinonen J, Salo J. PV diclofenac in post-thoracotomy pain. Br J Anaesth 1992; 68: 474-480.
13. Power I, Chambers WA, Greer IA, Ramage D, Simon E. Platelet function after intramuscular diclofenac. Anaesthesia 1990; 45: 916-919.